Abivax to Present Data on Obefazimod at Digestive Disease Week
Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight…
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical…
